mAbxience Appoints Jurgen Van Broeck as New CEO finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Teva Pharmaceuticals International, a subsidiary of Teva Pharmaceutical Industries, has entered into a strategic licensing agreement with mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma.
Teva and mAbxience enter into a strategic global partnership for in-licensing of an oncology biosimilar candidate
Agreement signals a major step in mAbxience s global expansion strategy and.
Teva Pharmaceutical Industries Limited: Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.